IMVT – Immunovant Inc
Investors holding1
Combined shares70,140
Combined reported value$2.4M
IMVT chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.
Ownership
| Investor | % of their portfolio | Change | Shares | Reported value | Period |
|---|---|---|---|---|---|
| David Einhorn | 0.07 | Reduced 25.0% | 70,140 | $2.4M | Q3 2026 |
Activity: last 4 quarters
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | David Einhorn | Reduced 25.0% | 70,140 | 0.02 |
| Q1 2026 | David Einhorn | New | 93,520 | 0.07 |
Added: opened or increased
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q1 2026 | David Einhorn | New | 93,520 | 0.07 |
Reduced: reduced or closed
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | David Einhorn | Reduced 25.0% | 70,140 | 0.02 |
History
1 peakQ3 2026: 1 tracked investors
20232026
Shares held, last 8 quarters
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| David Einhorn | 70.1K | 93.5K | 93.5K | – | – | – | – | – |
– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).